Complementary Peptides For Beta-Amyloid 29-42 Peptide
    1.
    发明申请
    Complementary Peptides For Beta-Amyloid 29-42 Peptide 审中-公开
    β-淀粉样蛋白29-42肽的互补肽

    公开(公告)号:US20080193947A1

    公开(公告)日:2008-08-14

    申请号:US11576081

    申请日:2005-10-06

    IPC分类号: G01N33/53 C07K14/00

    CPC分类号: C07K14/775

    摘要: The invention relates to peptides derived from the wild type ApolipoproteinE3 peptidic fragment 270-287 (ApoE WT) of sequence EDMQRQWAGLVEKVQAAV (SEQ ID NO: 2), having improved interaction with the β-Amyloid peptidic fragment 29-42 (Aβ 29-42) GAIIGLMVGGVVIA (SEQ ID NO: 1), in a [Aβ 29-42/ApoE mutant n] complex.

    摘要翻译: 本发明涉及源自具有改善的与β-淀粉样蛋白肽片段29-42(Abeta 29-42)的相互作用的序列EDMQRQWAGLVEKVQAAV(SEQ ID NO:2)的野生型载脂蛋白E3肽段270-287(ApoE WT) GAIIGLMVGGVVIA(SEQ ID NO:1),在[Abeta 29-42 / ApoE突变体n]复合物中。

    Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
    6.
    发明授权
    Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives 有权
    可取代的8-氰基-1-环丙基-7-(2,8-二氮杂双环[4.3.0] - 壬烷-8-基)-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸 酸及其衍生物

    公开(公告)号:US06323213B1

    公开(公告)日:2001-11-27

    申请号:US09125191

    申请日:1998-08-13

    IPC分类号: A61K31407

    CPC分类号: C07D471/04 A01N43/90

    摘要: The present invention relates to novel optionally substituted 8-cyano-1-cyclo-propyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives, of the general formula (I) in which R1 represents hydrogen, C1-C4-alkyl which is optionally substituted by hydroxyl, methoxy, amino, methylamino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl, R2 represents hydrogen, benzyl, C1-C3-alkyl, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl, radicals having the structures —CH═CH—COOR3, —CH2CH2COOR3, —CH2CH2CN, —CH2CH2COCH3 or —CH2COCH3, in which R3 represents methyl or ethyl, or a radical of the general structure R4—(NH—CHR5—CO)n—, in which R4 represents hydrogen, C1-C3-alkyl or the radical —COO-tert-butyl, R5 represents hydrogen, C1-C4-alkyl, hydroxyalkyl, aminoalkyl, thioalkyl, carboxyalkyl or benzyl and n is 1 or 2, and Y is oxygen or sulfur, the process for their preparation and their use in antibacterial compositions.

    摘要翻译: 本发明涉及新的任选取代的8-氰基-1-环丙基-7-(2,8-二氮杂双环[4.3.0]壬烷-8-基)-6-氟-1,4-二氢-4- 甲氧基,氨基,甲基氨基或二甲基氨基取代的C 1 -C 4 - 烷基,或(5-甲基-2-羟基喹啉羧酸)或其衍生物,其中R 1表示氢, 氧代-1,3-二氧杂环戊烯-4-基)甲基,R 2表示氢,苄基,C 1 -C 3 - 烷基,(5-甲基-2-氧代-1,3-二氧杂环戊烯-4-基)甲基, 结构-CH = CH-COOR 3,-CH 2 CH 2 COOR 3,-CH 2 CH 2 CN,-CH 2 CH 2 COCH 3或-CH 2 COCH 3,其中R 3表示甲基或乙基,或通式结构R4-(NH-CHR5-CO)n - 的基团,其中R4 代表氢,C 1 -C 3 - 烷基或-COO-叔丁基,R 5表示氢,C 1 -C 4 - 烷基,羟基烷基,氨基烷基,硫代烷基,羧基烷基或苄基,n是1或2,Y是氧或硫, 其制备方法及其在抗菌组合物中的应用。